HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
CompletedNCT01446328

Comparing Three Antipsychotic Medicines for Early Psychosis

About this titleRead the official source — NCT01446328
Medication studyAges 16+Austria + NorwaySchizophrenia
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 16 years.

Listed locations
Innsbruck and 3 more locationsSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateOctober 2011
Recruitment status
Completed
Enrollment listed in the registry
151
Sponsor
Haukeland University Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Austria, Norway
Age range
Over 16 Years
Official registry ID
NCT01446328
Official title
Show the full official title

Bergen Psychosis Project 2 - The Bergen-Stavanger-Innsbruck-Trondheim Study

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Innsbruck, Austria · Bergen, Norway · Stavanger, Norway

1 more locations
  • Trondheim, Norway

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Haukeland University Hospital, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including Amisulpride, Aripiprazole and Olanzapine.

Who was this study for?

Listed age limits: from 16 years.

Want to explore more studies?

Explore studies